Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing.
There is a growing recognition of the importance of protein kinases in the control of alternative splicing. To define the underlying regulatory mechanisms, highly selective inhibitors are needed. Here, we report the discovery and characterization of the dichloroindolyl enaminonitrile KH-CB19, a pote...
Κύριοι συγγραφείς: | Fedorov, O, Huber, K, Eisenreich, A, Filippakopoulos, P, King, O, Bullock, A, Szklarczyk, D, Jensen, L, Fabbro, D, Trappe, J, Rauch, U, Bracher, F, Knapp, S |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2011
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing.
ανά: Fedorov, O, κ.ά.
Έκδοση: (2011) -
7,8-dichloro-1-oxo-β-carbolines as a versatile scaffold for the development of potent and selective kinase inhibitors with unusual binding modes.
ανά: Huber, K, κ.ά.
Έκδοση: (2012) -
Regulation of influenza A virus mRNA splicing by CLK1
ανά: Artarini, A, κ.ά.
Έκδοση: (2019) -
CLK2 blockade modulates alternative splicing compromising MYC‐driven breast tumors
ανά: Fernando Salvador, κ.ά.
Έκδοση: (2018-05-01) -
Pharmacological inhibition of CLK2 activates YAP by promoting alternative splicing of AMOTL2
ανά: Maya L Bulos, κ.ά.
Έκδοση: (2023-12-01)